VectorPoint’s cohesive team of Managing Directors, Operating Partners, Advisors and other Investment Professionals bring target sector operational experience and, with many team members, also a successful track record in investing in and advising seed and early stage companies. This experience brings significant value work to assist companies, boards of directors and management teams advise and portfolio companies we invest in as they navigate through business challenges.

The VectorPoint team consists of individuals with a broad array of backgrounds and experience in management, accounting and finance, commercialization, manufacturing, sales and technology. Together we provide patient and dedicated support to teams we work with, helping them take their companies to the next level.



Jolene Anderson brings extensive experience in advising, mentoring and connecting early stage and growth stage companies with the strategic advice and resources required to scale their product or service. She has provided investor and media relations, executive coaching and has significant experience in providing advice for alternative financing, exit strategy and access to grant funding. Ms. Anderson has over 25 years’ experience in advising companies, in the Pacific Rim and North America. Her career experience includes senior development strategist for various private companies and investor relations for a public company, focused on STEM education.

Previously, Jolene worked as a commercial real estate Broker in WA State, where she was a Vice President for a local commercial real estate firm for 12 years. Her role included selling personal and real property, master planned communities, businesses, hotels and providing strategic workout advice to property owners, with assets in excess of $100 million. Her client list included Fortune 500 companies, attorneys, appraisers, financing sources, insurance companies, senior housing developers, hospitality companies and banks. She has also worked as a commercial appraiser for one of the leading appraisal firms in the Pacific NW, where she appraised master planned communities, medical facilities and hotels. She has also provided feasibility services for senior living communities, hospitality and medical spa facilities, and access to capital for commercial real estate clients. She is currently licensed with Coldwell Banker Bain Commercial as part of a team of experienced commercial real estate brokers. In 2010/2011, Ms. Anderson was invited to serve on the Mayor’s Green Task Force for the City of Seattle in evaluating the feasibility and best practice for bringing the housing stock in the City of Seattle more compliant with sustainable standards.


Don is co-founder of VectorPoint Ventures were he currently brings his extensive experience in early stage and growth stage investing, portfolio company management, entrepreneurship and finance to bear.  He has over 25 years of experience in board, finance and operational roles in a variety of industries and disciplines.  In his career he has served in several operational and leadership functions, including business development, finance, information technology, strategic planning and implementation, investment banking, and corporate development.   He has founded or co-founded several ventures and has held key management positions in several small and middle market companies, including serving as VP Finance, CFO, COO and board director positions in both private and public companies.


Rick has more than thirty years’ experience as a successful entrepreneur, company creator, active lead investor and venture capitalist. Rick is a co-founder of and advisor to VectorPoint Ventures. Rick is also currently Founder and President of Pillar Management, an Oregon based group of seasoned professional investors and entrepreneurs who have made active investments in over fifty companies primarily based in the Northwest. Pillar Management has been responsible for raising over $130 million and assists its portfolio companies through operations, strategic planning, developing management teams, serving on boards and advisory boards, strategic alliances and capital expansion. He has been involved in successful initial public stock offerings and mergers and acquisitions, resulting in many positive liquidity events.

Rick is a co-founder and former Director of Metro One Telecommunications, an Oregon based NASDAQ Company. Rick was instrumental in helping the company grow from a start-up to a nationwide company with revenues approaching $300 million. He helped pioneer enhanced directory assistance which served two thirds of the US population, employing over 7,000 people as 31 branch locations throughout the United States. During Rick’s involvement with the company, Metro One achieved a market capitalization of well over $1 billion and provided exceptional returns to its investors. Metro One was named one of the most outstanding and fastest growing companies by both Forbes and Fortune Magazine.


Brendan Rauw brings 20 years of management and leadership experience with life science companies and startups, including market assessment, company formation, licensing and business development, intellectual property strategy, research and development, organizational design, marketing effectiveness, salesforce optimization, and operations.
Previously, Brendan served as Vice President of Technology Transfer and Business Development at Oregon Health and Science University (OHSU). In this role, they increased the commercialization of OHSU’s intellectual property and research, and introduced an Entrepreneur-in-Residence program. Prior to joining OHSU, Brendan was Associate Vice Chancellor and Executive Director of Entrepreneurship at UCLA, responsible for leading the office and overseeing diverse programs to encourage innovation and entrepreneurship. While at UCLA, they founded Westwood Technology Transfer, an independent 501(c)(3) formed to manage intellectual property on behalf of the university.


David Starr has extensive management and leadership experience in life sciences and consumer products spanning all facets of operations and company stages – from company formation through explosive growth. His experience includes product definition, market research and analysis, distribution planning, sales management, product and technical support, manufacturing planning, financial operations, HR, engineering management, intellectual property and patent strategy, quality and regulatory management, fund raising, business development, clinical study design, medical education, healthcare economics and reimbursement.
Mr. Starr has spent the past 25 years in the medical device sector with an eye towards developing affordable, and easy to use medical technology that address today’s critical needs and what it takes to achieve commercial success. He is adept at working with clinicians in a variety of specialties to focus efforts on what is clinical actionable, “doable” from an engineering perspective and address large markets with clear unmet needs. These clinical areas include, emergency medicine, trauma, cardiology, radiology, anesthesiology, nursing, primary care, and first responders. Mr. Starr has raised over $50 million of investor money from angels, corporations, and venture capital firms including several overseas VC’s.



Sarah Brinker has dedicated her career to protecting the environment. She spent five years in Advancement-Communications at Sierra Club HQ in San Francisco, raising funds for national campaigns like the Beyond Coal Campaign. She then spent two years at new solar financing nonprofit RE-volv, spearheading partnerships and building out the development infrastructure. There, she landed RE-volv’s largest grant ever from the Leonardo DiCaprio Foundation. Itching to move the needle on the corporate side, Sarah earned an MBA in sustainable business practices from the University of Oregon. While there, as president of the Net Impact Graduate Chapter, the leadership team and she launched the wildly successful Impact Investing Forum with guest speakers from around the country. Upon graduation, Sarah moved to Portland, OR and now works with the Global Sustainability Engagement team at Nike. Sarah’s comprehensive knowledge of corporate environmental sustainability and deep skillsets in relationship membership have empowered her success.


Duffy has 40 years of experience in the life science industry. This experience includes positions in medical device, pharmaceutical and biotechnology firms. Early in his career he worked in a variety of strategy, finance, marketing and general management roles, both domestic and international, for Baxter Laboratories. Duffy subsequently became the Managing Director for the Canadian subsidiary of Boots Pharmaceutical. In the past 25-30 years, he has served as President or CEO for a number of biotech and medical device firms, primarily based in the New England area. These firms include ConjuChem, Inc., Anika Therapeutics, Zelos Therapeutics, Pacgen, and Ischemix Inc. Duffy has raised ~$250 million in equity for the companies he has run, encompassing investments from public offerings, venture capital investors and angel investors. He has IPO’ed two companies and has negotiated a number of partnering/licensing agreements. He has overseen the successful preclinical and clinical development of many biopharmaceuticals and medical devices in a variety of therapeutic areas.


David Eastman has over 35 years of executive management, product marketing and management, operations, strategic marketing, start-up venture development and new product launch experience marketing life science, high technology, and telecom products.

Mr. Eastman currently is the Chief Executive Officer of Gamma Therapeutics, an Oregon early stage biotechnology venture developing medical devices for cardiovascular disease risk assessment, surgical therapy and combat casualty care based upon the use of human clotting proteins.

Prior to Gamma Therapeutics, Mr. Eastman was the interim CEO of Yecuris, a biotechnology venture developing humanized mouse models for use in Life Science drug discovery. Mr. Eastman developed the business model for Yecuris, raised $3.0 M in venture capital and angel funding and developed strategic partnerships with five of the world’s leading pharmaceutical companies–AstraZeneca, Merck, Pfizer, GlaxoSmithKline and Roche–and two of the world’s leading cell suppliers, Lonza & BD Biologicals. Mr. Eastman sits on the Board of Directors of four Life Science start-ups including NeuraMedica, OmnEcoil, Sympano and MagnetoOrganics. In his role as an OTRADI Business Incubator biomentor, Mr. Eastman is currently mentoring several OBI start-ups in winning NIH/NSF multi-million dollar grants including Caregiven, Veana Therapeutics and Motusi.


Greg has over 30 years of global consumer brand experience that includes over a decade as CEO/President/Board/Founder/Chairman. His experience ranges from Fortune 500 companies to start ups. Greg consistently finds and executes strategic paths to successful company and brand performance. He has won numerous major awards for his ability to create, grow, and turnaround companies in fast pace industries that include footwear/apparel, cosmetics, personal care, and household products. Industry awards include: Fragrance of The Year, Footwear Brand of the Year, and Finalist NW Startup of the Year.

As a talented and seasoned senior executive with Colgate-Palmolive and Unilever he was responsible for successfully building and turning around billion dollar global brands such as Colgate Dental Care, Palmolive Brands, Vaseline and Ponds Skin Care. As a CEO/President and Board Member for leading footwear companies Greg brought his expertise to build wholesale and retail teams to grow leading brands such as Dr. Marten’s, Florsheim, and Naturalizer. His start-up experience includes creating a footwear company to save women’s feet from the damage caused by high heels, Oh! Shoes, Inc.



David is founder and CEO of Sparrow Pharmaceuticals, Inc., a clinical stage company that is developing next-generation corticosteroid medications. Previously he was a pharmaceutical R&D executive for 18 years at Abbott and AbbVie, where he led clinical trials and drug discovery teams, and was a pioneer in the field of personalized medicine. Dr. Katz has consulted for both the Food & Drug Administration and the National Institutes of Health.

David enjoys mentorship of life sciences companies. Since moving to Portland Oregon in 2018, he has been an entrepreneur-in-residence at Oregon Health Sciences University. As a member of Chicago Innovation Mentors, he advised nascent companies from the University of Chicago and the University of Illinois at Chicago. David is also an experienced angel investor (Keiretsu Forum, Chicago ArchAngels) who invests mainly in companies with potential to improve human health, mitigate anthropogenic climate change, or reduce socioeconomic inequality.


Hannah is a food startup community & ecosystem developer. While co-founding and scaling The Better Bean Company she intimately experienced the barriers to success. Since exiting from the company in 2018, she has become a business consultant and advisor. As a business advisor to the Small Business Development Center’s “Getting Your Recipe to Market Program” she helps launch numerous new companies into the ecosystem every 6 months. She has taken steps to make this next phase more navigable. Her first project is a Google Group for founders and leaders of Pacific Northwest Packaged Food & Beverage companies. It is now an active and growing community where members resource connections and solutions from each other. Hannah is also involved in BUILT Oregon as a mentor to the food companies in the BUILT accelerator.


David McFeeters-Krone is an experienced commercialization and business development executive with over 25 years-experience at MIT, NASA-RTTC, Intel, and his own firm. Most recently, he is the author and the program manager for a Manufacturing Extension Partnership (OMEP) grant to engage small manufacturers with the 14 institutes. In the course of his practice, he has reviewed dozens of commercialization plans, founded two successful companies (Scribe-X, Rute Foundations), is an adjunct professor at Portland State University, and serves on the advisory board of several firms (Innovation Assets Group, Rute Foundations, Kerstech, TangiTek, and Oregon Inc.).

His current and past clientele include Sharp Technology Ventures, P&G, Deloitte, DoD, NASA, OHSU, Providence, and the ManufacturingUSA Institutes. He has served on the NSF SBIR review committee, and prepared winning NSF SBIR, NIST, Business Oregon and other grant proposals. He was also the chief author of the successful proposal to fund the OTRADI signature research center.


Dr. Molly H. Shor supports two angel investment groups – E8 Angels and Keiretsu Forum Northwest – on deal flow, deal review, due diligence and outreach to entrepreneurs. As a Senior Fellow for E8, a clean technology angel investment group, Dr. Shor supervises PhD and post-doctoral fellows who assist in deal flow screening and due diligence. She also serves on and leads some due diligence teams. As Impact Committee Chair for Keiretsu Forum Northwest, Dr. Shor runs committee deal review meetings, and recruits and screens deal flow. Dr. Shor serves as program chair for the annual Keiretsu/E8 co-hosted Impact Forum – organizing speakers, recruiting suitable companies to apply, and supporting the screening process. Dr. Shor served as Keiretsu’s technical due diligence team lead for one deal. She enjoys coaching entrepreneurs and the deal screening process. Dr. Shor regularly attends the Clean Technology Alliance breakfast forums and tracks the clean technology landscape.


Ken Vaughn is the Director of Impact Investments for VertueLab, Oregon’s cleantech Signature Research Center that catalyzes the development of new technologies to reverse climate change and build a new green economy. He manages the program that provides grants to university researchers and makes investments in cleantech startup companies. The program is designed to accelerate research and technology development, remove barriers to customer adoption, and catalyze follow-on investments by private investors. He collaborates with innovators, entrepreneurs, investors, mentors, support organizations, and senior management talent to help assemble the elements necessary for launching successful businesses in the cleantech sector. He is not compensated by VPV as an advisor.

Mr. Vaughn is an accomplished professional with broad experience spanning executive management, engineering, marketing, strategic planning, product development, operations, economic development, and early-stage Investing. He has experience in nonprofits, entrepreneurial companies, and multi-national corporations in leadership, staff roles, and line roles.


Larry has over 35 years of experience as a CFO and consultant working with early and growth stage companies. He works with clean technology companies and other technology industry enterprises. He has worked with a wide range of venture capital and angel investor backed companies. Many of the companies he has supported have been on multiple fastest-growing companies lists, best places to work for lists, and/or awarded a Most Admired company listing. Larry was the managing member for three Angel Oregon investors groups. Larry was a judge and mentor for Cleantech Open competitions and speaks and advises for the Cascadia Cleantech Accelerator. He founded Willeman Strategy Partners Inc in 2002.


Patti White is the Co-founder and CEO of Hemex Health.  Patti brings 25 years of experience in medical technology and has launched over 20 successful products, including many in emerging markets.  Her experience spans cardiology, critical care, pain medicine, ophthalmology, behavioral health and diagnostics and has experience in two previous start-ups, a mid-size company and a large corporation.   Previously Patti ran marketing for Hewlett Packard’s $400M PC business and for HP’s $100M Cardiology division. Her first start-up invented a low-cost patient monitor with sales of over $100M.   She has raised over $80M in grant, angel, venture and corporate funding. Patti holds an MBA from The Wharton School at the University of Pennsylvania, and a degree in International Business from the University of Washington.